<DOC>
	<DOC>NCT02198092</DOC>
	<brief_summary>This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.</brief_summary>
	<brief_title>Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Colonic Neoplasms</mesh_term>
	<mesh_term>Adenomatous Polyposis Coli</mesh_term>
	<mesh_term>Colorectal Neoplasms, Hereditary Nonpolyposis</mesh_term>
	<criteria>Informed consent provided Age &gt; or = to 18 years of age Patient group FAP Clinical diagnosis of familial adenomatous polyposis Patient group Lynch syndrome Clinical diagnosis of Lynch syndrome Patient group MAP Clinical diagnosis of MYHassociated polyposis and presence of more than 20 colon polyps Control group (FAP) Genetically related family member of patient Patients: Able and willing to attend routine followup as advised Controls, i.e. relatives of patients: Willingness to give blood at each routine followup as advised for the diseased relative Known infection with Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), or Hepatitis C Virus (HCV) Current diagnosis of colorectal cancer Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>familial adenomatous polyposis</keyword>
	<keyword>multiple adenomatous polyposis</keyword>
	<keyword>lynch syndrome</keyword>
	<keyword>hnpcc</keyword>
	<keyword>colorectal cancer</keyword>
	<keyword>genetic syndrome</keyword>
	<keyword>epigenomics</keyword>
	<keyword>septin9</keyword>
</DOC>